A major role of LEAP is to provide researchers centralized access to relevant scholarly materials, data, publications, and conference proceedings from ongoing laboratory and clinical research that catalog progress in the field.
Press Release: Long-acting injectable cabotegravir is highly effective for the prevention of HIV infection in cisgender men and transgender women who have sex with men. View in "RECENT PUBLICATIONS".
Find technical and non-technical publications, meeting summaries, and relevant links to resources on LA/ER antiretrovirals
Throughout the year, lectures, conferences and workshops are held to help move the field of LA/ER drugs forward. When possible, summaries, recordings or white papers resulting from these activities will be provided here.
DAIDs provides resources to help support a global research portfolio on HIV/AIDS, its related co-infections, and co-morbidities. Find here targeted resources around LA/ER product development.
Be informed about the latest research and clinical studies being done in long-acting, extended release drugs for HIV and TB.
These resources are focused on efforts to advance the development of drug formulations, e.g. targeted product profiles, collaborations, etc.
These resources are focused on regulatory policy regarding of long-acting antiretrovirals